Biomagnetics Diagnos Valuation
| BMGPDelisted Stock | USD 0.0001 0.00 0.00% |
Biomagnetics Diagnos seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Biomagnetics Diagnos from analyzing the firm fundamentals such as Current Valuation of 259.92 K, return on equity of -0.62, and EBITDA of (553.42 K) as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Biomagnetics Diagnos' price fluctuation is very steady at this time. Calculation of the real value of Biomagnetics Diagnos is based on 3 months time horizon. Increasing Biomagnetics Diagnos' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Biomagnetics Diagnos' intrinsic value may or may not be the same as its current market price of 0.0001, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.5E-5 | Hype 1.0E-4 |
The intrinsic value of Biomagnetics Diagnos' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Biomagnetics Diagnos' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Biomagnetics Diagnos helps investors to forecast how Biomagnetics stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Biomagnetics Diagnos more accurately as focusing exclusively on Biomagnetics Diagnos' fundamentals will not take into account other important factors: Biomagnetics Diagnos Total Value Analysis
Biomagnetics Diagnos is currently forecasted to have valuation of 259.92 K with market capitalization of 57, debt of 121.51 K, and cash on hands of 2.6 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Biomagnetics Diagnos fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
259.92 K | 57 | 121.51 K | 2.6 K |
Biomagnetics Diagnos Asset Utilization
One of the ways to look at asset utilization of Biomagnetics is to check how much profit was generated for every dollar of assets it reports. Biomagnetics Diagnos shows a negative utilization of assets of -0.31 percent, losing $0.003119 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Biomagnetics Diagnos shows how discouraging it operates for each dollar spent on its assets.Biomagnetics Diagnos Profitability Analysis
Net Loss for the year was (518.06 K) with profit before overhead, payroll, taxes, and interest of 0.About Biomagnetics Diagnos Valuation
The delisted stock valuation mechanism determines Biomagnetics Diagnos' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Biomagnetics Diagnos based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Biomagnetics Diagnos. We calculate exposure to Biomagnetics Diagnos's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Biomagnetics Diagnos's related companies.Biomagnetics Diagnostics Corporation, a medical device and biotechnology company, designs, patents, and markets diagnostic equipment and immunoassays, and other biotechnologies. The company was founded in 1997 and is based in Orangevale, California. Biomagnetics Diagnos is traded on OTC Exchange in the United States.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Consideration for investing in Biomagnetics Stock
If you are still planning to invest in Biomagnetics Diagnos check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biomagnetics Diagnos' history and understand the potential risks before investing.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |